Filing Details

Accession Number:
0001471608-13-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-26 17:50:51
Reporting Period:
2013-07-24
Filing Date:
2013-07-26
Accepted Time:
2013-07-26 17:50:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
10456 Baxter International Inc BAX Surgical & Medical Instruments & Apparatus (3841) 360781620
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1471608 P. David Scharf One Baxter Parkway
Deerfield IL 60015
Corporate Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $1 Par Value Acquisiton 2013-07-24 12,000 $51.21 29,425 No 4 M Direct
Common Stock, $1 Par Value Acquisiton 2013-07-24 13,680 $52.50 43,105 No 4 M Direct
Common Stock, $1 Par Value Acquisiton 2013-07-24 39,702 $53.80 82,807 No 4 M Direct
Common Stock, $1 Par Value Disposition 2013-07-24 53,422 $73.81 29,385 No 4 S Direct
Common Stock, $1 Par Value Disposition 2013-07-26 2,016 $73.17 27,369 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $1 Par Value Stock Option (Right to Buy) Acquisiton 2013-07-24 12,000 $0.00 12,000 $51.21
Common Stock, $1 Par Value Stock Option (Right to Buy) Acquisiton 2013-07-24 13,680 $0.00 13,680 $52.50
Common Stock, $1 Par Value Stock Option (Right to Buy) Acquisiton 2013-07-24 39,702 $0.00 39,702 $53.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-03-15 No 4 M Direct
0 2019-03-04 No 4 M Direct
19,851 2021-03-04 No 4 M Direct
Footnotes
  1. Price reflects weighted average sales price. Range of prices for transactions are $73.51 through $74.50. Full information regarding the number of shares sold at each separate price will be provided by the issuer upon request.
  2. Shares all sold at same price. A total of 9,944 shares were retained from exercise of options by reporting person.
  3. The options become exercisable in three equal annual installments beginning on the first anniversary of the date of grant.